Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development

Developmental Dynamics

Volumn 213, Issue 1, 1998, Pages 27-38

  Teesalu, Tambet ^a,b   Blasi, Francesco ^a,b   Talarico, Daniela ^a,b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HSRaffaele   (Italy)

Author keywords

Fibrin; LDL receptor related protein; Mouse; Null mutant; Placental development; Plasminogen activator inhibitor type 1; Trophoblast; UPA receptor; Urokinase; Uterine epithelium

Indexed keywords

FIBRIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE; UROKINASE RECEPTOR;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; EMBRYO; ENDOMETRIUM; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; IN SITU HYBRIDIZATION; MOUSE; MUTANT; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; TROPHOBLAST;

ANIMALIA; MURINAE;

EID: 0031854390     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0177(199809)213:1<27::aid-aja3>3.0.co;2-%23     Document Type: Article

References (54)

1. Abrahamsohn PA, Zorn TM. Implantation and decidualization in rodents. J. Exp. Zool. 1993;266:603-628.
2. Afonso S, Romagnolo L, Babiarz B. The expression and function of cystatin C and Cathepsin L during mouse embryo implantation and placentation. Development 1997;124:3415-3425.
3. Aharoni D, Meiri I, Atzmon R, Vlodavsky I, Amsterdam A. Differential effect of components of the extracellular matrix on differentiation and apoptosis. Current Biol. 1997;7:43-51.
4. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr. Opin. Cell. Biol. 1989;1:974-982.
5. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani, NS, Hawkes SP, Werb Z. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996;122: 1723-1736.
6. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator in cancer metastasis: A review. Int. J. Cane. 1997;72:1-22.
7. Belin D, Vassalli JD, Combepine C, Godeau F, Nagamine Y, Reich E, Kocher HP, Duvoisin RM. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur. J. Biochem. 1985;148:225-232.
8. Blasi F, Conese M, Møller LB, Pedersen N, Cavallaro U, Cubellis MV, Fazioli F, Hernandez-Marrero L, Limongi P, Munoz-Canovez P, Resnati M, Riittinen L, Sidenius N, Soravia E, Soria MR, Stopelli MP, Talarico D, Teesalu T, Valcamonica S. The urokinase receptor: Structure, regulation and inhibitor-mediated internalization. Fibrinolysis 1994;8:182-188.
9. Bugge TH, Flick MJ, Daugherty CC, Degen JL. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 1995;9:794-807.
10. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen J. L. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996;87:709-719.
11. Carmeliet P, Collen D. Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice. Fibrinolysis 1996;10: 195-213.
12. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan R.C. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419-424.
13. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 1997;17:439-444.
14. Colosi P, Talamantes F, Linzer DI. Molecular cloning and the expression of mouse placental lactogen I complementary deoxyribonucleic acid. Mol. Endocrinol. 1987;1:767-776.
15. Cross JC, Werb Z, Fisher S. Implantation and the placenta: Key pieces of the development puzzle. Science 1994;266:1508-1518.
16. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. Integrin switching regulates normal trophoblast invasion. Development 1994;120:3657-3666.
17. Devy L, Noel A, Baramova E, Bajou K, Trentesaux C, Jardillier JC, Foidart JM, Jeannesson P. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells. Biochem. Biophys. Res. Comm. 1997;238:842-846.
18. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espana F, Loskutoff DJ, Schleef RR. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine growth retardation. Blood 1994;84:143-150.
19. Fox H, Jones CJP. Pathology of trophoblast. In: Loke YW, Whithe A, eds. Biology of Trophoblast. Amsterdam New York Oxford:Elsevier, 1983;138-180.
20. Graham CH, McCrae KR. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am. J. Obstet. Gynecol. 1996;175:555-562.
21. Gu Y, Jow GM, Moulton BC, Lee C, Sensibar JA, Park-Sarge OK, Chen TJ, Gibori G. Apoptosis in decidual tissue regression and reorganization. Endocrinology 1994;135:1272-1279.
22. Herz J, Clouthier D E and Hammer RE. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation [correction published in Cell 1993 May 7;73428]. Cell 1992;71:411-421.
23. Huffman LH,Wooding FBP. Giant and binucleate trophoblast giant cells of mammals. J. Exp. Zool. 1993;266:559-577.
24. Jones JL, Walker RA. Control of matrix metalloproteinase activity in cancer. J. Pathol. 1997;183:377-379.
25. Knobil K. The origin, properties and fate of trophoblast in the mouse. In:. Loke YW, Whyte A, eds. Biology of Trophoblast. Amsterdam New York Oxford: Elsevier, 1983;23-70.
26. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein. Ann. Rev. Biochem. 1994;63:601-637.
27. Kristensen P, Eriksen J, Blasi F, Danø K. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J. Cell Biol. 1991;115:1763-1771.
28. Lescisin KR, Varmuza S, Rossant J. Isolation and characterization of a novel trophoblast-specific cDNA in the mouse. Genes Dev. 1988;2: 1639-1646.
29. Lopez MF, Dikkes P, Zurakowski D, Villa-Komaroff L. Insulin-like growth factor II affects the appearance and glycogen content of glycogen cells in the murine placenta. Endocrinology 1996;137:2100-2108.
30. Masson R, Lefebvre O, Noel A, El Fahime M, Chernard M-P, Wendung C, Kebers F, LeMeur M, Dierich A, Foidart J-M, Basset P, Rio MC. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cells malignancy. J. Cell Biol. 1998;140:1535-1543.
31. Matrisian LM, Hogan BLM. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Top. Dev. Biol. 1990;24:219-257.
32. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M., Garbisa S, Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J. 1997;16:2319-2332.
33. Nykjær A, Petersen CM, Møller B, Jensen PH, Mœstrup SK, Holtet TL, Etzerodt M, Thøghersen HC, Munch M, Andreasen P, Gliemann J. Purified alpha-2 macroglobulin receptor/LDL receptor related protein binds urokinase-plasminogen activator inhibitor type-1 complex. Evidence that alpha-2 macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 1992;267:14543-14546.
34. Ploplis V,Carneliet P,Vazirzadeh S,Van Vlaenderen I,Moons L,Plow E, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice. Circulation 1995;92:2585-2593.
35. Ploplis, VA, French EL,Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998;91:2005-2009.
36. Prendergast GC, Diamond LE, Dahl D, Cole MD. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 1990;10:1265-1269.
37. Redline RW, Lu CY. Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Implications for maternal-fetal immunological relationship. Lab. Invest. 1989;61:27-36.
38. Redline RW, Chernicky CL, Tan HQ, Ilan J, Ilan J. Differential expression of insulin-like growth factor-II in specific regions of the late (post day 9.5) murine placenta. Mol. Reprod. Dev. 1993;36:121-129.
39. Rozzo C, Chiesa V, Caridi G, Pagnan G, Ponzoni M. Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion. Int. J. Cancer. 1997;70:688-698.
40. Sappino AP, Huarte J, Belin D, Vassalli JD. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J. Cell. Biol. 1989;109:2471-2479.
41. Sappino AP, Huarte J, Vassalli J-D, Belin D. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J. Clin. Invest. 1991;87:962-970.
42. Shimonovitz S, Hurwitz A, Dushnik M, Anteby E, Geva-Eldar T, Yagel S. Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: A possible mechanism for control of trophoblast invasion. Am. J. Obstet. Gynecol. 1994;171: 832-838.
43. Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA 1985;82:4939-4943.
44. Strickland S, Richards WG. Invasion of the trophoblasts. Cell 1993;71: 355-357.
45. Syrovets T,Tippler B,Rieks M,Simmet T. Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood 1997; 89:4574-4583.
46. Talarico D, Ittmann MM., Bronson R, Basilico C. A Retrovirus carrying the K-fgf oncogene induces diffuse meningeal tumors and soft-tissue fibrosarcomas. Mol. Cell. Biol. 1993;13:1998-2010.
47. 2MR/LRP genes. Mech. Dev. 1996;56:103-116.
48. Tsirka SE, Bugge TH, Degen JL, Strickland S. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc. Natl. Acad. Sci. USA 1998;94:9779-9781.
49. Van Leuven F, Stas L, Raymakers L, Overbergh L, De Strooper B, Hilliker C, Lorent K, Fias E, Umans L, Torrekens S, Serneels L, Moechars D, Van den Berghe H. Molecular cloning and sequencing of the murine alpha-2-macroglobulin receptor cDNA. Biochim. Biophys. Acta 1993;1173:71-74.
50. Vassalli J-D, Belin D. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett. 1987;214:187-191.
51. Vassalli J-D, Sappino AP, Belin D. The plasminogen activators/ plasmin system. J. Clin. Invest. 1991;4:1067-1072.
52. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. MMP-9/geletinaseB is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998;93:411-422.
53. Wilkinson DG, Bailes JA, McMahon AP. Expression of the protooncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell 1987;50:79-88.
54. Zhou Y, Damsky CH., Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J. Clin. Invest. 1993;91:950-960.